551 related articles for article (PubMed ID: 15308697)
1. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; Doerr HW; von Laer D
J Virol; 2004 Sep; 78(17):9007-15. PubMed ID: 15308697
[TBL] [Abstract][Full Text] [Related]
2. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
Hofmann H; Hattermann K; Marzi A; Gramberg T; Geier M; Krumbiegel M; Kuate S; Uberla K; Niedrig M; Pöhlmann S
J Virol; 2004 Jun; 78(12):6134-42. PubMed ID: 15163706
[TBL] [Abstract][Full Text] [Related]
3. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
Buchholz UJ; Bukreyev A; Yang L; Lamirande EW; Murphy BR; Subbarao K; Collins PL
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9804-9. PubMed ID: 15210961
[TBL] [Abstract][Full Text] [Related]
4. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.
Temperton NJ; Chan PK; Simmons G; Zambon MC; Tedder RS; Takeuchi Y; Weiss RA
Emerg Infect Dis; 2005 Mar; 11(3):411-6. PubMed ID: 15757556
[TBL] [Abstract][Full Text] [Related]
5. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
Moore MJ; Dorfman T; Li W; Wong SK; Li Y; Kuhn JH; Coderre J; Vasilieva N; Han Z; Greenough TC; Farzan M; Choe H
J Virol; 2004 Oct; 78(19):10628-35. PubMed ID: 15367630
[TBL] [Abstract][Full Text] [Related]
6. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.
Fukushi S; Mizutani T; Saijo M; Kurane I; Taguchi F; Tashiro M; Morikawa S
J Med Virol; 2006 Dec; 78(12):1509-12. PubMed ID: 17063504
[TBL] [Abstract][Full Text] [Related]
9. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein.
Han DP; Kim HG; Kim YB; Poon LL; Cho MW
Virology; 2004 Aug; 326(1):140-9. PubMed ID: 15262502
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus.
Schwegmann-Weßels C; Glende J; Ren X; Qu X; Deng H; Enjuanes L; Herrler G
J Gen Virol; 2009 Jul; 90(Pt 7):1724-1729. PubMed ID: 19264610
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
13. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
[TBL] [Abstract][Full Text] [Related]
14. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
[TBL] [Abstract][Full Text] [Related]
15. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
16. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
Fukushi S; Watanabe R; Taguchi F
Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
[TBL] [Abstract][Full Text] [Related]
18. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
[TBL] [Abstract][Full Text] [Related]
19. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
[TBL] [Abstract][Full Text] [Related]
20. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
